InvestorsHub Logo
Followers 88
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: None

Monday, 06/15/2020 3:14:09 PM

Monday, June 15, 2020 3:14:09 PM

Post# of 64728
one of 29 TSOI products

NanoStilbene
1) will be used as adjuvant for numerous existing immunotherapies
2) enhances efficacy of FDA cleared cancer therapies
3) works with checkpoint inhibitors family like rituximab,cetuximab, and herceptin
4) estimated combined annual sales of ritux, cetux, and herceptin = 20 Billion

https://www.globenewswire.com/news-release/2019/08/26/1906525/0/en/Therapeutic-Solutions-International-Announces-Positive-Clinical-Data-Using-NanoStilbene-to-Stimulate-Immune-System-in-Advanced-Cancer-Patients.html

https://www.globenewswire.com/news-release/2019/08/26/1906525/0/en/Therapeutic-Solutions-International-Announces-Positive-Clinical-Data-Using-NanoStilbene-to-Stimulate-Immune-System-in-Advanced-Cancer-Patients.html



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News